Wall Street researchers just used Claude to design a drug. The experiment has spawned a new investment thesis.


For years, artificial-intelligence evangelists have boasted about the technology’s capacity to revolutionize drug development and medical research.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *